Matrixx Initiatives, Inc. F2Q10 (Qtr End 09/30/09) Earnings Call Transcript – Seeking Alpha (blog)
|
Matrixx Initiatives, Inc. F2Q10 (Qtr End 09/30/09) Earnings Call Transcript
Seeking Alpha (blog) For the Zicam brand in the quarter, we made up half of the loss sales of the withdrawn nasal products through a 53% increase in sales of our oral Cold … Zicam Recall: Manufacturer Says FDA Not Changing Stance on Zicam UPDATE 1-Matrixx says FDA unwilling to change stance on Zicam Matrixx (MTXX) Shares Tumble as FDA Won't Reverse Position on Zicam |
FDA Sticks to Zicam Cold Remedy Warning Letter on Loss of Smell …
The US Food and Drug Administration (FDA) has refused to back down from a warning letter sent to Zicam manufacturers, Matrixx Initiatives, Inc., regarding the potential dangers of its over-the-counter cold medication.
See the article here:
FDA Sticks to Zicam Cold Remedy Warning Letter on Loss of Smell …
Zicam Recall: Manufacturer Says FDA Not Changing Stance on Zicam – AboutLawsuits.com
|
Zicam Recall: Manufacturer Says FDA Not Changing Stance on Zicam
AboutLawsuits.com According to Matrixx Initiatives, Inc., maker of Zicam cold remedy, the FDA is not going to reverse a prior stance that prevents the company from marketing … UPDATE 1-Matrixx says FDA unwilling to change stance on Zicam Matrixx (MTXX) Shares Tumble as FDA Won't Reverse Position on Zicam Market Report — Short Stories (MTXX) |
Matrixx Initiatives, Inc. Reports Fiscal 2010 Second Quarter Sales and Net Income – Reuters
|
Matrixx Initiatives, Inc. Reports Fiscal 2010 Second Quarter Sales and Net Income
Reuters Zicam, LLC, its wholly-owned subsidiary, markets and sells Zicam® products in the cough and cold category. The Company markets Zicam brand pharmaceuticals, … |
The Langoliers are going to get you!! (MTXX) – Motley Fool
|
The Langoliers are going to get you!! (MTXX)
Motley Fool Earnings report for ZICAM is tonight folks…. Will Varchild suffer more pain at the hands of the Langoliers? Or will he get on board the Jet and take off … |
HEADLINE STOCKS-U.S. small/midcap stocks on the move on Oct 26 – Reuters
|
HEADLINE STOCKS-U.S. small/midcap stocks on the move on Oct 26
Reuters … has indicated that it is unwilling to reverse its position regarding the warning letter issued on company's nasal versions of Zicam cold remedy. … |
(For large-cap stocks on the move, click on [WATCH/US]) – Reuters
|
(For large-cap stocks on the move, click on [WATCH/US])
Reuters … has indicated that it is unwilling to reverse its position regarding the warning letter issued on company's nasal versions of Zicam cold remedy. … |
VERIZON COMMUNICATIONS INC, $28.77, down 0.3 pct – Forbes
|
VERIZON COMMUNICATIONS INC, $28.77, down 0.3 pct
Forbes … indicated that it was unwilling to reverse its position regarding the warning letter issued on the company's nasal versions of Zicam cold remedy. … |
HEADLINE STOCKS-us small/midcap stocks to watch on Oct 26 – Reuters
|
HEADLINE STOCKS-us small/midcap stocks to watch on Oct 26
Reuters … has indicated that it is unwilling to reverse its position regarding the warning letter issued on company's nasal versions of Zicam cold remedy. … |
Early Movers: Pump Up the Volume – TheStreet.com
|
Early Movers: Pump Up the Volume
TheStreet.com In June, Matrixx said the FDA issued a letter to the company with concerns about the marketing of Zicam. Matrixx will report earnings after the closing bell … |